Onderneming IPI Legacy Liquidation Co
Aandelen
IMPL
US45258K1097
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 160
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John D. Hoekman
FOU | Founder | 43 | 01-01-08 |
Sheena Aurora
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scott Youmans
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Sarah Wille
HRO | Human Resources Officer | - | 01-01-19 |
Lynn Gold
LAW | General Counsel | 67 | 01-07-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Nelson
BRD | Director/Board Member | 60 | 01-02-17 |
Diane Wilfong
BRD | Director/Board Member | 62 | 17-09-19 |
David Allison
BRD | Director/Board Member | 42 | 01-06-19 |
John D. Hoekman
FOU | Founder | 43 | 01-01-08 |
Darren Cline
BRD | Director/Board Member | 59 | 12-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 23 900 031 | 23 880 031 ( 99,92 %) | 0 | 99,92 % |
Bedrijfsgegevens
Impel Pharmaceuticals, Inc.
201 Elliott Avenue West Suite 260
98119, Seattle
+206 568 1466
http://impelpharma.com![Adres IPI Legacy Liquidation Co(IMPL)](https://cdn.zonebourse.com/static/address/121925378.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |